Skip to content

Predict 5-Year Survival in Elderly Gastric Cancer

Machine Learning Models to Predict 5-Year Post-Surgery Survival of Older Gastric Cancer Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06208046
Enrollment
2187
Registered
2024-01-17
Start date
2023-07-01
Completion date
2024-01-04
Last updated
2024-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer, Machine Learning

Keywords

Gastric Cancer, Elderly, Oxidative Stress, Machine Learning, Overall Survival

Brief summary

In this study, elderly patients with gastric cancer who underwent radical gastrectomy in Union Hospital Affiliated to Fujian Medical University from 2012 to 2018 were included as a derived cohort, and the training set and internal validation set were randomly divided by 4:1. Machine learning strategies of random forest, decision tree and support vector machine are used to construct survival prediction model. Each model was tested in an internal validation set and an external validation set consisting of patients from two other large medical centers.

Detailed description

This is a retrospective, supervised learning, data mining study.

Interventions

None listed

Sponsors

Fujian Medical University Union Hospital
CollaboratorOTHER
Fujian Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* (1) GC diagnosis confirmed by abdominal computed tomography (CT) or biopsy; (2) age ≥65 years at diagnosis; (3) underwent radical surgical resection without evidence of distant metastasis; and (4) availability of complete clinical and pathological data.

Exclusion criteria

* (1) postoperative pathology confirming non-gastric primary tumors; (2) distant metastasis; (3) incomplete clinical data; and (4) other concurrent malignancies within five years.

Design outcomes

Primary

MeasureTime frameDescription
5-year overall survival5 years or 60 months.Survival status at 5 years: survival, death, survival with tumor, deletion.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026